Aslan Pharmaceuticals Ltd.

Aslan Pharmaceuticals Ltd.

Aslan Pharmaceuticals Ltd.

Overview
Date Founded

2010

Headquarters

83 Clemenceau Avenue, No. 12-03 UE Square, Singapore, 239920, SGP

Type of Company

Public

Employees (Worldwide)

38

Industries

Biotechnology
Pharmaceuticals

Company Description

Aslan Pharmaceuticals Ltd. is a clinical-stage oncology-focused biopharmaceutical company, which engages in the development of novel therapeutics. Its pipeline includes varlitinib, ASLAN003, ASLAN004, and ASLAN002. The firm's portfolio focuses on validated growth pathways applied to new patient segments, novel immune checkpoints, and novel cancer metabolic pathways. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Executives & Employees

Chief Executive Officer & Chairman of the Board

Chief Operating Officer

General Counsel

Vice President, Commercial & Head of China

Vice President, Finance

Professional

Board of Directors

Chief Executive Officer & Chairman of the Board at Aslan Pharmaceuticals Ltd.

Founder at Cenova Ventures

Co-Founder & General Partner at BioVeda Capital Singapore (Pte) Ltd.

Independent Director at Aslan Pharmaceuticals Ltd.

Managing Director at Dornier Medtech Systems GmbH

Chief Financial Officer & Senior Vice President, Finance at Heron Therapeutics, Inc.

Chairman at Kang Chun Venture Capital Co. Ltd.

Paths to Aslan Pharmaceuticals Ltd.
Potential Connections via
Relationship Science
You
Aslan Pharmaceuticals Ltd.
Owners & Shareholders
Details Hidden

Prince Street Capital Management (PSCM) manages investment funds which invest primarily in emerging and frontier markets. The firm seeks to generate capital appreciation on a long-term compound basis. To meet this objective, PSCM employs long and short investment strategies in this asset class. They also utilize an investment strategy that focuses on long-term investments chosen with regard both to growth prospects and valuation, with less concern for short term volatility in stock prices, to achieve their absolute return investment objective. In addition to equities, investments may include derivatives, derivatives and forward foreign exchange contracts. Assets are generally invested in securities and other investments that are denominated in currencies other than the US Dollar. PSCM may also employ the use of leverage in futures contracts, options warrants and other derivative instruments.

Details Hidden

Prince Street Capital Management (PSCM) manages investment funds which invest primarily in emerging and frontier markets. The firm seeks to generate capital appreciation on a long-term compound basis. To meet this objective, PSCM employs long and short investment strategies in this asset class. They also utilize an investment strategy that focuses on long-term investments chosen with regard both to growth prospects and valuation, with less concern for short term volatility in stock prices, to achieve their absolute return investment objective. In addition to equities, investments may include derivatives, derivatives and forward foreign exchange contracts. Assets are generally invested in securities and other investments that are denominated in currencies other than the US Dollar. PSCM may also employ the use of leverage in futures contracts, options warrants and other derivative instruments.

Recent Transactions
Details Hidden

Aslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Transaction Advisors
Underwriter

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Underwriter

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Auditor

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Associate

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Associate

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Legal Advisor

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Clients

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Hyundai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products, health food drinks and medical equipment. Its major products include ethical drugs (ETC) and over-the-counter (OTC) drugs. The company was founded on July 16, 1965 and is headquartered in Cheonan, South Korea.

Key Stats and Financials As of 2018
Market Capitalization
$4.29B
Total Enterprise Value
$3.24B
Earnings Per Share
$-8.49
Three Year Compounded Annual Growth Rate Of Revenue
0%
Debt TEV
0.11x
TEVNet Income
-2.55x
EBITDA
$-1.27B
Total Equity
$936M
Total Debt
$346M
Net Profit
$-1.27B
Revenue
$0
Investors
Details Hidden

Goodman Capital invests in companies located in across Asia and USA. The frim provides financing for seed, early, later and Pre-IPO round. The firm invest in across the broad range of sectors tech, biotech and real estate.

Details Hidden

XinChen Ventures is a private company headquartered in Taiwan that operates as private equity firm.

Suppliers
Merck KGaA Hospitals & Patient Services | Darmstadt, HE

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

CSL Limited Medical Support Services | Parkville, VIC

CSL Ltd. is a biopharmaceutical company, which engages in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma-derived and recombinant products, and operates plasma collection networks through CSL Plasma. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.

Array BioPharma Inc. Pharmaceuticals | BOULDER, CO

Array BioPharma, Inc. engages in the research, development, and commercialization of targeted small molecule drugs for the treatment of cancer and other high-burden diseases. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Regeneron Pharmaceuticals, Inc. Pharmaceuticals - Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Sanofi Pharmaceuticals - Paris, IF

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Aslan Pharmaceuticals Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Aslan Pharmaceuticals Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Aslan Pharmaceuticals Ltd..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/aslan-pharmaceuticals-ltd-208942588
  • https://relationshipscience.com/organization/aslan-pharmaceuticals-ltd-208942588